Q2 2024 Holdings
Filed 2024-08-14 | 115 holdings | $5.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.0M | 2,718,735 | 6.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $305.7M | 337,600 | 6.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $270.5M | 15,021,721 | 5.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $252.1M | 3,273,000 | 5.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $219.4M | 493,100 | 4.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $208.8M | 900,900 | 4.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $186.0M | 7,959,538 | 3.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $162.9M | 1,316,000 | 3.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $156.1M | 1,173,300 | 3.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $124.8M | 2,979,828 | 2.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $113.1M | 2,372,333 | 2.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $102.1M | 646,000 | 2.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $91.5M | 269,000 | 1.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $91.1M | 168,100 | 1.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $89.9M | 209,100 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $80.5M | 1,785,571 | 1.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $78.6M | 9,240,887 | 1.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $75.1M | 5,779,071 | 1.5% |
| Natera Inc(NTRA) | COM | 632307104 | $74.4M | 687,500 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $73.0M | 132,000 | 1.4% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $70.8M | 151,000 | 1.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $64.3M | 1,707,331 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $61.7M | 448,200 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $60.8M | 250,300 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $60.1M | 795,900 | 1.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $58.0M | 1,268,734 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $57.4M | 1,280,800 | 1.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $57.0M | 112,000 | 1.1% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $56.2M | 3,027,328 | 1.1% |
| Icon PLC(ICLR) | SHS | G4705A100 | $54.6M | 174,100 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $51.9M | 7,619,135 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $50.0M | 1,302,800 | 1.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $49.8M | 2,605,615 | 1.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $46.1M | 73,114,592 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $44.0M | 812,906 | 0.9% |
| Amgen Inc(AMGN) | COM | 031162100 | $42.1M | 134,900 | 0.8% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $41.8M | 3,229,977 | 0.8% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $41.6M | 10,909,256 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $41.4M | 2,861,801 | 0.8% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $40.4M | 2,252,987 | 0.8% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $40.4M | 349,221 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $39.5M | 1,925,300 | 0.8% |
| Geron Corp(GERN) | COM | 374163103 | $37.9M | 8,930,252 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $33.6M | 862,362 | 0.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $32.9M | 289,900 | 0.6% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $32.1M | 12,048,773 | 0.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $28.9M | 704,842 | 0.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $28.9M | 706,475 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $28.4M | 672,416 | 0.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $25.8M | 3,406,335 | 0.5% |